Global Medical REIT stock maintains rating at Citizens JMP

Published 09/06/2025, 10:28
Global Medical REIT stock maintains rating at Citizens JMP

On Monday, Citizens JMP analysts reaffirmed a Market Perform rating for Global Medical (TASE:BLWV) REIT stock (NYSE: GMRE), currently trading at $6.38. According to InvestingPro analysis, the company maintains a FAIR Financial Health Score, with metrics suggesting the stock is currently undervalued. The firm noted that the company appears to be nearing the announcement of a new CEO, as contract negotiations seem to be progressing.

Last week, Global Medical REIT announced a reduction in its dividend to an annual rate of $0.60 from $0.84, still offering an attractive 9.4% yield. This adjustment decreases the payout ratio from 92% to 72% for fiscal year 2025, which is viewed as a positive step for the company’s long-term sustainability. InvestingPro data shows the company maintains strong liquidity, with current assets exceeding short-term obligations.

The dividend cut is intended to create a more stable environment for the incoming CEO, reducing potential challenges. Despite the stock trading at a 36% discount to its net asset value, analysts do not foresee the company deploying capital from its balance sheet. Instead, they expect capital deployment through its joint venture with Heitman.

The reiterated rating reflects the analyst’s assessment of the company’s current financial strategy and its impact on future operations.

In other recent news, Global Medical REIT Inc (NYSE:GMRE). reported its financial results for the first quarter of 2025, showing a mixed performance. The company exceeded earnings per share (EPS) expectations with 3 cents compared to the anticipated 1 cent, but it missed revenue projections, reporting $34.6 million against the forecasted $35.34 million. Despite the revenue shortfall, Global Medical REIT reaffirmed its full-year 2025 Adjusted Funds from Operations (AFFO) guidance, projecting $0.89 to $0.93 per share. Additionally, the company completed the acquisition of a five-property portfolio for $69.6 million, demonstrating its ongoing commitment to strategic growth. The portfolio acquisition aligns with their strategy to maintain high occupancy rates and expand their real estate holdings. In other developments, Global Medical REIT held its annual meeting where seven directors were elected to the board, and Deloitte & Touche LLP was ratified as the independent registered public accounting firm for the fiscal year. These recent activities reflect the company’s focus on governance and strategic expansion in the healthcare real estate sector.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.